Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Yi

Showing results (551-560 of 570) with videos related to

Pageof 57
Sort By:
Cell Reports|February 2, 2023
Spatial compartmentalization of signaling imparts source-specific functions on secreted factorsElena Groppa, Paolo Martini, Nima Derakhshan, et al.
Frontiers in Oncology|April 1, 2022
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate CancerXiao-Ping Qin, Qi-Ji Lu, Cheng-Huizi Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 1, 2020
Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary RehabilitationYuan-Yang Cheng, Chin-Ming Chen, Wei-Chun Huang, et al.
International Journal of Medical Sciences|March 9, 2026
Integrin αvβ3 is a Potential Therapeutic Target in CholangiocarcinomaFitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|February 9, 2026
Chinese Clinical Practice Guidelines for Auditory Neuropathy (gCAN), Xiao-Nan Wu, Tao Shi, et al.
Cell Stem Cell|February 4, 2018
Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic PotentialRobert N Judson, Marco Quarta, Menno J Oudhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)Tian-You Zhan, Tao Zhang, Wen-Qing Wang, et al.
Journal of Translational Medicine|February 26, 2026
Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinomaZi-Lin Li, Sachin Kumar, San-Nan Yang, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Pageof 57

Showing results (551-560 of 570) with videos related to

Sort By:
Pageof 57
Cell Reports|February 2, 2023
Spatial compartmentalization of signaling imparts source-specific functions on secreted factorsElena Groppa, Paolo Martini, Nima Derakhshan, et al.
Frontiers in Oncology|April 1, 2022
CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate CancerXiao-Ping Qin, Qi-Ji Lu, Cheng-Huizi Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 1, 2020
Rehabilitation programs for patients with COronaVIrus Disease 2019: consensus statements of Taiwan Academy of Cardiovascular and Pulmonary RehabilitationYuan-Yang Cheng, Chin-Ming Chen, Wei-Chun Huang, et al.
International Journal of Medical Sciences|March 9, 2026
Integrin αvβ3 is a Potential Therapeutic Target in CholangiocarcinomaFitria Sari Wulandari, Chih-Yang Wang, Dana R Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|February 9, 2026
Chinese Clinical Practice Guidelines for Auditory Neuropathy (gCAN), Xiao-Nan Wu, Tao Shi, et al.
Cell Stem Cell|February 4, 2018
Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic PotentialRobert N Judson, Marco Quarta, Menno J Oudhoff, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)Tian-You Zhan, Tao Zhang, Wen-Qing Wang, et al.
Journal of Translational Medicine|February 26, 2026
Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinomaZi-Lin Li, Sachin Kumar, San-Nan Yang, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractionsWilliam A Carroll, Robert J Altenbach, Hao Bai, et al.
Pageof 57